SCHEMBL4421671

SCHEMBL4421671

NC(=O)c1sc2nc(-c3ccccc3)nc(-c3cccc(NC(=O)Oc4ccc([N+](=O)[O-])cc4)c3)c2c1N

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRAF P15056 13/20 0.51
PDE4A P27815 4/20 0.43
PDE4B Q07343 4/20 0.43
PDE4C Q08493 4/20 0.43
PDE4D Q08499 4/20 0.43
LIMK1 P53667 2/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
IKBKB O14920 1/20 0.40
MAPT P10636 2/20 0.39
GAA P10253 1/20 0.39
KDM4E B2RXH2 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4422648 0.90 LHCGR (0.50) BRAFMEN1KMT2ANPC1RAB9A
SCHEMBL4420434 0.88 LHCGR (0.51) BRAFPDE4APDE4BPDE4CPDE4D
SCHEMBL4422658 0.79 LHCGR (0.58) BRAFPDE4APDE4BPDE4CPDE4D
SCHEMBL5034024 0.78 LHCGR (0.65) MEN1KMT2ANPC1RAB9A
SCHEMBL4423554 0.78 BRAF (0.58) BRAFPDE4APDE4BPDE4CPDE4D
SCHEMBL5024685 0.78 BRAF (0.58) BRAFPDE4APDE4BPDE4CPDE4D
SCHEMBL5043443 0.76 MAPT (0.47) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL5043447 0.76 MAPT (0.47) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL4419064 0.75 BRAF (0.64) BRAFPDE4APDE4BPDE4CPDE4D
SCHEMBL4425936 0.74 BRAF (0.58) BRAFPDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618963-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2009-11-17 US disclosed
US-20070197527-A1 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-08-23 US disclosed
US-7229990-B2 Bicyclic heteroaromatic compounds N.V. ORGANON (NL) 2007-06-12 US disclosed
CN-1247594-C Bicyclic heteroaromatic compounds OKZO NOBEL N V (NL) 2006-03-29 CN disclosed
CN-1462273-A Bicyclic heteroaromatic compounds OKZO NOBEL N V (NL) 2003-12-17 CN disclosed
US-20030225113-A1 Bicyclic heteroaromatic compounds MERCK SHARP & DOHME B.V. (NL) 2003-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225113-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR BRAF 4474/4885PDE4A 1417/4885PDE4B 1292/4885
US-20070197527-A1 Bicyclic heteroaromatic compounds NR5A1, CYP19A1, FSHR BRAF 4242/4885PDE4A 1703/4885PDE4B 1680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.